An open‐label, multi‐centre, post‐marketing study to assess the efficacy and safety of a plasma‐derived VWF/FVIII concentrate in patients with von Willebrand disease

Saved in:
Bibliographic Details
Published inHaemophilia : the official journal of the World Federation of Hemophilia Vol. 30; no. 1; pp. 236 - 240
Main Authors Miesbach, Wolfgang, Halimeh, Susan, Platokouki, Helen, Podolak‐Dawidziak, Maria, Zdziarska, Joanna, Korczowski, Bartosz, Chowdary, Pratima, Austin, Steve, Millar, Carolyn, Alamelu, Jayanthi, Rogosch, Tobias, Pabinger, Ingrid
Format Journal Article
LanguageEnglish
Published England Wiley Subscription Services, Inc 01.01.2024
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ISSN:1351-8216
1365-2516
DOI:10.1111/hae.14868